Conduit Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $720,120 | $698,221 | $671,992 | $624,861 |
Gross Profit | 263,566 | -885 | -828 | -190 |
EBITDA | 87,542 | -6,282 | -5,143 | -4,380 |
EBIT | -7,167 | -5,971 | -4,577 | |
Net Income | 255,421 | -7,118 | -6,028 | -4,753 |
Net Change In Cash | 720,120 | 698,221 | 671,992 | 624,861 |
Free Cash Flow | 180,709 | 65,325 | -2,581 | -24,761 |
Cash | 389,887 | 3,838 | 3,332 | 2,130 |
Basic Shares | 39,882 | 540 | 137 | 32 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,715,194 | $922,222 | $0 | $0 |
Gross Profit | 1,031,172 | -457 | ||
EBITDA | 315,692 | -15,839 | 3,053 | -4,887 |
EBIT | -16,296 | -324 | -3,160 | |
Net Income | 237,522 | -17,802 | -535 | -4,887 |
Net Change In Cash | 2,715,194 | 922,222 | 0 | 0 |
Free Cash Flow | 218,692 | -9,733 | -7,725 | -2,266 |
Cash | 389,887 | 554 | 4,228 | 345 |
Basic Shares | 40,210 | 7 | 5 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$13.16 |
2025-06-30 | -$5.46 |
2025-03-31 | -$19.86 |
2024-12-31 | -$2.15 |
